Authors
Latest:
A Conversation on Women's Leadership and Career in Medicine: Jennifer Frontera, MDThe professor of neurology at NYU Grossman School of Medicine talked about the importance of aligning leadership roles with personal passions for women in the field of neurology pursuing their careers in medicine. [WATCH TIME: 5 minutes]
Latest:
AI-Powered Patient Advocacy: Amplifying Health Care VoicesAI could revolutionize patient advocacy by bridging communication gaps between patients and providers, and the synergy of medicine and AI offers a promising avenue for enhanced patient care and operational efficiency.
Latest:
Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 ScoreThe director of the Montefiore Headache Center will provide further insight into migraine care at the 1st Annual International Congress on the Future of Neurology, to be held September 27-28 in New York City.
Latest:
Rodolfo Savica, MD, PhD: Dyskinesias in Atypical ParkinsonismThe associate professor of neurology at Mayo Clinic spoke about the findings of a population-based cohort study seeking to investigate the incidence of levodopa-induced dyskinesia in atypical parkinsonism.
Latest:
Laura Julian, PhD: The Floodlight Open MS DatabaseThe principal medical science director at Genentech spoke about the decisions behind the tools being used for measurement, and what the neurologists can get from the data.
Latest:
Laura T. Safar, MD: Carefully Addressing Mental Health in MSThe director of MS neuropsychiatry at Brigham and Women’s Hospital spoke of the importance of not oversimplifying the approach to mental health disorders in individuals with MS, and how the collaborative care model can help.­­­
Latest:
Reena Mehra, MD, MS: Advances in Sleep Apnea Treatment DevicesThe director of the Sleep Disorders Research Program at Cleveland Clinic Lerner College of Medicine detailed the advancements that have been made with OSA treatment devices.
Latest:
David Holtzman, MD: Difficulties Identifying Dementia With Lewy BodiesThe current president of the American Neurological Association specifically mentioned the work some groups are doing with small molecule imaging methods to help with this issue.
Latest:
Irina Pikuleva, PhD: Activating CYP46A1 with EfavirenzThe Carl F. Asseff Professor of Ophthalmology and the Director of the Visual Sciences Research Center at Case Western Reserve University spoke about the beginnings of her work with efavirenz.
Latest:
Changes Needed to Improve SMA Costs: Lisa Belter, MPHThe director of research analytics at Cure SMA detailed the ways to decrease care management costs for patients with spinal muscular atrophy and the role incoming treatments can play.
Latest:
Concluding Thoughts on Biosimilars in Multiple SclerosisAmy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.
Latest:
The Brisk Evolution of Multiple Sclerosis CareWe are closer than ever to individualized management of MS, and keeping up with the rapidly changing pace of MS care is challenging even for an MS specialist.
Latest:
New Horizons in Multiple SclerosisExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
Zachary Grinspan, MD, MS: Improving Adherence to Status Epilepticus ProtocolsThe director of the Pediatric Epilepsy Program is joined by an MD candidate from Weill Cornell Medicine to discuss the protocol used to treat patients with status epilepticus.
Latest:
Pierrick Arnal, PhD: Conducting Sleep Studies With the Dreem HeadbandThe vice president of science and medical at Dreem offered his opinion on how the company’s headband device can improve how sleep studies are conducted.
Latest:
Potential Layered Migraine Treatment Approaches to Research: Andrew Blumenfeld, MDThe director of the Headache Center of Southern California discussed research opportunities for layered treatment approaches in migraine.
Latest:
James Hendrix, PhD: Progress and Challenges in the Alzheimer SpaceHendrix spoke to the challenges he and colleagues come across, as well as his hope for the promising future.
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at HomeNoninvasive neuromodulation with TAPS is a safe and effective tool that offers particular utility in the age of COVID-19 when other treatment options may be less accessible.
Latest:
Gene Therapy Shows Robust Activity for Duchenne Muscular DystrophyA novel gene therapy has demonstrated impressive early results in a small sample of 3 children with Duchenne muscular dystrophy.
Latest:
An Emerging Framework for Parkinson Disease TherapeuticsThe diagnosis of Parkinson disease may seem straightforward at first, requiring neurologists to rely on their eyes and hands, but the treatment process can present challenges for both physicians and patients.
Latest:
Understanding the Evolving Care of Rehabilitation and Stroke RecoveryExplore innovative neurorehabilitation strategies for stroke recovery, emphasizing personalized approaches and advanced technologies to enhance patient outcomes.
Latest:
Peter Nakaji, MD: The State of Science for Epilepsy SurgeryThe chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.
Latest:
Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical CareThe postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.
Latest:
Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES TrialThe vice president of AstraZeneca’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.
Latest:
The Future Outlook for Alzheimer’s DiseaseSharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.
Latest:
Kathleen Hawker, MD: Clinical Findings for Satralizumab in Treating NMOSDThe group medical director of neuroscience at Genentech spoke to the findings recently presented at the 6th Annual Meeting of the European Academy of Neurology.
